mortality rates – Page 18 – Communicable Diseases Research

Clinical characteristics of adult patients hospitalized with laboratory-confirmed COVID-19 pneumonia

실험실에서 확인된 COVID-19 폐렴으로 입원한 성인 환자의 임상적 특징

Article

Published on 2021-02-012022-09-11
Journal: Journal of infection and chemotherapy : official j [Category] SARS, 치료제,

[키워드] acute respiratory distress acute respiratory distress syndrome Adult patients analyzed asymptomatic infection case sery Characteristics clinical Clinical characteristics Comorbidity coronavirus cough country COVID-19 COVID-19 pneumonia CRP diabetes Diabetes Mellitus died discharged Elderly patient elderly patients elevated eventually death Fever followed by heart disease heterogeneity hypertension ischemic heart disease İstanbul laboratory-confirmed leukopenia lymphocytopenia mortality rate mortality rates Outbreaks outcome overall mortality Patient patient cohort patient cohorts patients patients hospitalized patients with COVID-19 Pneumonia provide respiratory distress Retrospective study Shortness of breath single-center Symptom syndrome Treatment strategies Turkey Variation
[DOI] 10.1016/j.jiac.2020.10.020 PMC 바로가기 [Article Type] Article

Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?

COVID-19 또는 기타 바이러스성 질병의 세계적 발병이 신체 내부의 줄기 세포 저장소를 위협합니까?

Review

Published on 2021-02-012022-09-12
Journal: Stem cell reviews and reports [Category] MERS, 진단,

Effect of timing of implementation of containment measures on Covid-19 epidemic. The case of the first wave in Italy

Research Article

Published on 2021-01-292022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS,

Remdesivir: From Ebola to COVID-19

렘데시비르: 에볼라에서 코로나19까지

Review

Published on 2021-01-292022-09-11
Journal: Biochemical and Biophysical Research Communication [Category] 비임상, 치료제,

[키워드] acute respiratory syndrome adenosine Adenosine analogues animal coronavirus Animal coronaviruses antiviral activity antiviral drug antiviral drugs antiviral therapy approved candidate changed China clinical study coronavirus Coronavirus infection Coronavirus infections COVID-19 disease double blind drug Ebola Ebola virus Efficacy Epidemic HCoV Health highly pathogenic hospitalized patient hospitalized patients hosts Human human coronavirus human coronaviruses human-to-human transmission in vitro In vitro studies in vitro study inhibit initial initiated MERS Middle East Middle East respiratory syndrome Mild molecular mechanism mortality rate mortality rates nucleotide outbreak Pathogens Patient placebo controlled trial preclinical studies Randomized Remdesivir Replication respiratory Respiratory tract diseases RNA RNA dependent RNA polymerase SARS-CoV-2 SARS-CoV-2 coronavirus Severe acute respiratory syndrome shortening shown syndrome thought Time to recovery treated Treatment Trial upper respiratory tract USA virus zoonotic infection zoonotic infections
[DOI] 10.1016/j.bbrc.2020.11.043 PMC 바로가기 [Article Type] Review

Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic

진행중인 유행성 전염병 동안 SARS-CoV-2의 검출에 사용 가능한 분자 방법의 요약

Review

Published on 2021-01-282022-09-10
Journal: International Journal of Molecular Sciences [Category] MERS, 변종, 진단, 치료기술, 치료제,

[키워드] 501Y.V2 501Y.V2 variant affected B.1.1.7 variant caused Containment containment strategies Coronaviridae COVID-19 COVID-19 pandemic described detection Diagnosis diagnostic diagnostic protocol Evolution excess genetic variability genomic gold gold standard in silico analysis Laboratory laboratory diagnosis molecular molecular methods morbidity morbidity and mortality mortality rates Mutation no effect pandemic probes protocol protocols Region reliability respiratory respiratory sample Respiratory samples SARS-CoV-2 SARS-CoV-2 genome sensitivity situation South Africa target UK variant variants Viral viral genome virus virus variant
[DOI] 10.3390/ijms22031298 PMC 바로가기 [Article Type] Review

Using the Novel Mortality-Prevalence Ratio to Evaluate Potentially Undocumented SARS-CoV-2 Infection: Correlational Study

Original Paper

Published on 2021-01-272022-10-31
Journal: JMIR Public Health and Surveillance [Category] COVID-19, MERS,

The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries

Perspective

Published on 2021-01-252022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,

Cost‐effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa

Research Article

Published on 2021-01-222022-10-28
Journal: BMC health services research [Category] COVID-19,

Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial

중증 코로나19 환자에서 이카티반트 및 C1 에스테라제/칼리크레인 억제제의 효능 및 안전성 평가: 3군 무작위 대조 시험 연구 프로토콜

Study Protocol

Published on 2021-01-202022-09-10
Journal: Trials [Category] 비임상, 임상,

[키워드] accumulation ACE inhibitor ACE inhibitors ACE2 angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 animal models anti-inflammatory agents antibiotic antithrombotic therapy assigned binding bradykinin breath C1 esterase inhibitor cause Cell clinical clinical trial clinical trials cough COVID-19 Degradation dependent on driving Efficacy and safety eligible patient expressed Icatibant inactivation include Inflammatory inhibitor intravenously invasive ventilation leads lipopolysaccharide LPS lung lung inflammatory response Lungs mechanism mortality rates Non-invasive number Open-label oxygen parallel-group Pneumonia Pneumonitis Prophylactic Protein randomized clinical trial Randomized controlled trial Randomly receive reduce registry renal replacement therapy replacement therapy Respiratory failure SARS-CoV-2 severe COVID-19 patient severe COVID-19 patients Severity of disease Side effect single-center standard care Study protocol subcutaneously supplemental oxygen the cells Universal vasopressor support viral-induced virus
[DOI] 10.1186/s13063-021-05027-9 PMC 바로가기 [Article Type] Study Protocol

Can Optimum Solar Radiation Exposure or Supplemented Vitamin D Intake Reduce the Severity of COVID-19 Symptoms?

Review

Published on 2021-01-162022-10-30
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,